Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
European Journal of Pharmacology|October 4, 1989
Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoidJ J Feigenbaum, S A Richmond, Y Weissman, et al.The International Journal of Neuroscience|February 1, 1987
Diethylstilbestrol counteracts barbiturate narcosis and hypothermia in male miceR H Fishman, J J Feigenbaum, C Iser-Strenger, et al.The International Journal of Neuroscience|January 1, 1983
Morphine may not produce true catalepsyJ J Feigenbaum, J Yanai, B H Moon, et al.Pain|October 1, 1991
Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking propertiesR Zeltser, Z Seltzer, A Eisen, et al.Pharmacology, Biochemistry, and Behavior|February 1, 1982
The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypyJ J Feigenbaum, J Yanai, R B Blass, et al.Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates: 2. Characterization of the quantum yield of singlet oxygen generated by irradiation of dye-neuropeptide conjugatesJ J Feigenbaum, M D Choubal, D S Crumrine, et al.Neurochemical Research|February 1, 1997
On the synthesis of neurotransmitter receptor agonists with antagonist potentialD S Crumrine, M D Choubal, J R Kanofsky, et al.Clinical Biochemistry|October 1, 1990
The molecular basis of Tay-Sachs disease: mutation identification and diagnosisD J Mahuran, B L Triggs-Raine, A J Feigenbaum, et al.American Journal of Medical Genetics|April 12, 2001
DHCR7 genotypes of cousins with Smith-Lemli-Opitz syndromeM J Nowaczyk, T Heshka, B Eng, et al.Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates: 1. The synthesis of Cys-containing dye-neuropeptide conjugatesJ J Feigenbaum, M D Choubal, K Payza, et al.Pageof 5